Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Junjiao Ping

Datos Biográficos

ID7954474
NOMBREJunjiao Ping
NOMBRESJunjiao
APELLIDOPing
FIRMAPING J
AFILIACIONESZhongshan People's Hospital
ORCID0009-0001-6454-9444
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H0
  • BDNF genetic variants modulate the impact of childhood trauma on symptom dimensions in first-episode schizophrenia

    Open Access•Junjiao Ping, Yong Wu et al.•ARTICLE•Frontiers in Psychiatry•2026

    These findings demonstrate that BDNF polymorphisms act as genetic modifiers of trauma-related symptom expression, supporting a gene-environment interaction model underlying phenotypic heterogeneity in schizophrenia

  • The role of cognitive function in predicting metabolic risk in schizophrenia

    Open Access•Rui Li, R M J Li et al.•ARTICLE•Frontiers in Psychiatry•2026

    Modeling based on concise clinical and cognitive indicators can effectively achieve metabolic risk stratification in patients with schizophrenia. Rather than relying on a single algorithm, combining the complementary strengths of RF and SVM and selecting models according to specific clinical needs and data characteristics may improve the identification of high-risk individuals and support proactive intervention and management

  • Trends in incidence, prevalence, and disability-adjusted life years of schizophrenia in China from 1990 to 2021, with projections for 2022-2050

    Open Access•Jiawen Huo, Junyu Huo et al.•ARTICLE•Frontiers in Psychiatry•2025

    GBD 2021 data reveal a rising SCZ burden in China, especially in ASPR and ASDR, posing increasing public health challenges. Males bore a consistently higher burden, but the female burden increased faster than the global average, highlighting gender-specific concerns. Age patterns emphasize young and middle-aged populations as key targets for intervention. Projected increases in incidence and mortality call for enhanced, tailored prevention and tr…

  • Naloxone Alleviate the Severity of Delirium in Hospitalized Patients With Parkinsonism

    Open Access•Haiyan Jin, Jie Zhang et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: Delirium is common in geriatric with Parkinson's disease (PD). Treatments for delirium have generally been neuroleptics; however, antipsychotics have potential effect to block striatal dopamine D2 receptors and worsen symptom of parkinsonism. We explored whether naloxone can alleviate delirium in PD and other forms of parkinsonism. Patients and Methods: Patients with parkinsonism who met the delirium criteria of the Diagnostic and Statis…

Sin obras prominentes en esta página.

  • Naloxone Alleviate the Severity of Delirium in Hospitalized Patients With Parkinsonism

    Open Access•Haiyan Jin, Jie Zhang et al.•ARTICLE•Frontiers in Psychiatry•2021

    Purpose: Delirium is common in geriatric with Parkinson's disease (PD). Treatments for delirium have generally been neuroleptics; however, antipsychotics have potential effect to block striatal dopamine D2 receptors and worsen symptom of parkinsonism. We explored whether naloxone can alleviate delirium in PD and other forms of parkinsonism. Patients and Methods: Patients with parkinsonism who met the delirium criteria of the Diagnostic and Statis…

  • Trends in incidence, prevalence, and disability-adjusted life years of schizophrenia in China from 1990 to 2021, with projections for 2022-2050

    Open Access•Jiawen Huo, Junyu Huo et al.•ARTICLE•Frontiers in Psychiatry•2025

    GBD 2021 data reveal a rising SCZ burden in China, especially in ASPR and ASDR, posing increasing public health challenges. Males bore a consistently higher burden, but the female burden increased faster than the global average, highlighting gender-specific concerns. Age patterns emphasize young and middle-aged populations as key targets for intervention. Projected increases in incidence and mortality call for enhanced, tailored prevention and tr…

  • BDNF genetic variants modulate the impact of childhood trauma on symptom dimensions in first-episode schizophrenia

    Open Access•Junjiao Ping, Yong Wu et al.•ARTICLE•Frontiers in Psychiatry•2026

    These findings demonstrate that BDNF polymorphisms act as genetic modifiers of trauma-related symptom expression, supporting a gene-environment interaction model underlying phenotypic heterogeneity in schizophrenia

  • The role of cognitive function in predicting metabolic risk in schizophrenia

    Open Access•Rui Li, R M J Li et al.•ARTICLE•Frontiers in Psychiatry•2026

    Modeling based on concise clinical and cognitive indicators can effectively achieve metabolic risk stratification in patients with schizophrenia. Rather than relying on a single algorithm, combining the complementary strengths of RF and SVM and selecting models according to specific clinical needs and data characteristics may improve the identification of high-risk individuals and support proactive intervention and management

Medicine (2 obras) · Psychiatry (2 obras) · Psychology (2 obras) · Schizophrenia (object-oriented programming (2 obras) · Schizophrenia research and treatment (2 obras) · Alcoholism and Thiamine Deficiency (1 obras) · Anesthesia (1 obras) · Anesthesia and Sedative Agents (1 obras) · Brain-derived neurotrophic factor (1 obras) · Child Abuse and Trauma (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae